ABCG2 and neoplasm: Therefore, CS-promoting agents may be used as single agents for MDR tumor treatments, as well as agents re-sensitizing MDR tumors to the commonly employed drugs, killing selectively ABC transporters-expressing cells and/or reducing ABC transporters’ expressions/activity in resistant tumors.